FIELD: medicine.
SUBSTANCE: for the purpose of post-surgical treatment of cerebral tumours, memantine is prescribed in a dose of 10 mg daily for 5-7 days before radiation therapy, and in a dose of 20 mg during radiation therapy 4-6 hours before the radiation session. On completing the course of radiation therapy, memantine is prescribed in patients aged up to 60 years old in a dose of 10 mg for 2-3 months daily, in patients aged 60 and older in a dose of 20 mg for 5-6 months daily.
EFFECT: method enables providing the higher patients' quality of life with a view to cancellation of glucocorticoids, ensuring higher clinical effectiveness ensured by an increase of the medullary substance to radiation.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TEACHING MALIGNANT BRAIN GLIOMA | 2009 |
|
RU2402360C1 |
| METHOD OF TREATMENT OF MALIGNANT BRAIN TUMORS | 2015 |
|
RU2578472C1 |
| METHOD FOR TREATING PATIENTS WITH GLIAL CEREBRAL TUMOR | 2004 |
|
RU2261740C1 |
| METHOD OF SELECTING THE TACTICS OF CHEMORADIOTHERAPY AFTER RESECTION OF A RELAPSE OF BRAIN GLYOMA | 2017 |
|
RU2662091C1 |
| METHOD OF SELECTING TACTICS OF TREATING RECURRENCE OF MALIGNANT BRAIN GLIOMA | 2011 |
|
RU2470586C1 |
| METHOD FOR CHOOSING THE TACTICS OF CHEMORADIOTHERAPY AFTER RESECTION OF RECURRENT GLIOBLASTOMA OF THE BRAIN | 2022 |
|
RU2796321C1 |
| METHOD FOR CHOICE OF TREATMENT TACTICS FOR PATIENTS WITH GLIOMAS OF LOW MALIGNANCY DEGREES | 2010 |
|
RU2441599C1 |
| METHOD FOR CHOOSING THE TACTICS OF RADIATION THERAPY IN PATIENTS WITH MALIGNANT GLIOMAS | 2021 |
|
RU2765112C1 |
| METHOD OF THE TREATMENT OF PRIMARY GLIOBLASTOMA OF THE BRAIN | 2022 |
|
RU2801610C1 |
| METHOD FOR DETERMINING WAY FOR CARRYING OUT REPEATED REMOTE GAMMA-THERAPY IN MALIGNANT CEREBRAL GLIOMA RECURRENCE CASES | 2005 |
|
RU2269126C1 |
